ImmuPharma PLC Financial Flexibility Index
ImmuPharma PLC financial flexibility index. ImmuPharma PLC (IMM) has a Financial Flexibility Index of -0.81x as of June 2025. Free cash flow of GBX-1.00 Million (operating CF GBX-1.00 Million minus capex GBX0.00) represents -1% of total liabilities (GBX1.24 Million). See free cash flow generation of ImmuPharma PLC to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of ImmuPharma PLC (2004–2024)
Financial flexibility index of ImmuPharma PLC from 2004 to 2024. Historical Financial Flexibility Index trend for ImmuPharma PLC across 21 annual periods. Check IMM operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
ImmuPharma PLC Financial Flexibility Index by Year (2004–2024)
ImmuPharma PLC financial flexibility index by year from 2004 to 2024. Year-by-year free cash flow to debt coverage for ImmuPharma PLC. For the full cash flow conversion analysis, see ImmuPharma PLC operating cash flow efficiency.
| Year | Flexibility Index | Free Cash Flow (GBX) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.16x | GBX-1.77 Million | GBX-1.77 Million | GBX1.52 Million | ▼ -41.9% |
| 2023 | -0.82x | GBX-1.36 Million | GBX-1.36 Million | GBX1.67 Million | ▲ +46.9% |
| 2022 | -1.54x | GBX-2.24 Million | GBX-2.35 Million | GBX1.45 Million | ▲ +48.8% |
| 2021 | -3.02x | GBX-4.78 Million | GBX-4.83 Million | GBX1.58 Million | ▼ -28.2% |
| 2020 | -2.35x | GBX-2.97 Million | GBX-3.33 Million | GBX1.26 Million | ▲ +69.6% |
| 2019 | -7.74x | GBX-4.11 Million | GBX-4.22 Million | GBX531.87K | ▼ -73.3% |
| 2018 | -4.46x | GBX-4.62 Million | GBX-4.72 Million | GBX1.03 Million | ▼ -46.5% |
| 2017 | -3.05x | GBX-4.40 Million | GBX-4.42 Million | GBX1.44 Million | ▲ +45.3% |
| 2016 | -5.57x | GBX-6.48 Million | GBX-6.49 Million | GBX1.16 Million | ▼ -105.4% |
| 2015 | -2.71x | GBX-4.13 Million | GBX-4.15 Million | GBX1.52 Million | ▼ -72.9% |
| 2014 | -1.57x | GBX-2.14 Million | GBX-2.49 Million | GBX1.37 Million | ▲ +27.8% |
| 2013 | -2.17x | GBX-3.91 Million | GBX-3.91 Million | GBX1.80 Million | ▼ -39.9% |
| 2012 | -1.55x | GBX-3.24 Million | GBX-3.26 Million | GBX2.09 Million | ▲ +16.7% |
| 2011 | -1.86x | GBX-3.30 Million | GBX-3.37 Million | GBX1.77 Million | ▲ +56.5% |
| 2010 | -4.28x | GBX-6.77 Million | GBX-6.84 Million | GBX1.58 Million | ▼ -334.4% |
| 2009 | 1.82x | GBX11.97 Million | GBX11.96 Million | GBX6.56 Million | ▲ +253.6% |
| 2008 | -1.19x | GBX-2.57 Million | GBX-2.57 Million | GBX2.16 Million | ▲ +65.6% |
| 2007 | -3.45x | GBX-3.62 Million | GBX-3.63 Million | GBX1.05 Million | ▼ -638.1% |
| 2006 | -0.47x | GBX-525.00K | GBX-879.00K | GBX1.12 Million | ▼ -124.2% |
| 2005 | 1.93x | GBX27.00K | GBX27.00K | GBX14.00K | ▲ +285.7% |
| 2004 | 0.50x | GBX1.00K | GBX1.00K | GBX2.00K | — |